Updated Aug 23, 2026
/Cerebras Systems doubled core revenue in Q2 as GAAP hardware sales fell 23%/Camden CEO Alex Jessett redirects $1.625 billion California exit to Sun Belt acquisitions and share buybacks/Quantum Computing Inc. reports 9,000% revenue jump as quantum stocks move in tandem/SpaceX's bid to acquire Cognition AI stalls as startup targets $40 billion valuation/Werewolf Therapeutics shares double on Ambros merger and $150 million PIPE/Treasury bond buyback expansion lifts gold and bitcoin as dollar retreats/Cerebras Systems doubled core revenue in Q2 as GAAP hardware sales fell 23%/Camden CEO Alex Jessett redirects $1.625 billion California exit to Sun Belt acquisitions and share buybacks/Quantum Computing Inc. reports 9,000% revenue jump as quantum stocks move in tandem/SpaceX's bid to acquire Cognition AI stalls as startup targets $40 billion valuation/Werewolf Therapeutics shares double on Ambros merger and $150 million PIPE/Treasury bond buyback expansion lifts gold and bitcoin as dollar retreats

Glancy Prongay Wolke & Rotter Continues Securities Fraud Probe Into GE HealthCare Technologies

LOS ANGELES, July 8. Glancy Prongay Wolke & Rotter LLP said it is continuing a securities fraud investigation into GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of the company's

By Julian Merrick2 min read
Share